Caroline Anna Clara Hyde

Dr. Caroline Anna Clara Hyde

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Eleonora MontuoriEleonora Montuori
Eleonora Montuori
CHCaroline Anna Clara Hyde
Caroline Anna Clara Hyde
FCFrancesco Crea
Francesco Crea
JGJon Golding
Jon Golding
Chiara LauritanoChiara Lauritano
Chiara Lauritano
Prostate cancer is the most common cancer in men, with over 52,000 new cases diagnosed every year. Diagnostics and early treatment are potentially hindered by variations in screening protocols, still largely reliant on serum levels of acid phosphatase and prostate-specific antigen, with tumour diagnosis and grading relying on histopathological examination. Current treatment interventions vary in terms of efficacy, cost and severity of side effects, and relapse can be aggressive and resistant to the current standard of care. For these reasons, the scientific community is looking for new chemotherapeutic agents. This review reports compounds and extracts derived from marine organisms as a potential source of new drugs against prostate cancer. Whilst there are several marine-derived compounds against other cancers, such as multiple myeloma, leukemia, breast and lung cancer, already available in the market, the presently collated findings show how the marine environment can be considered to hold potential as a new drug source for prostate cancer, as well. This review presents information on compounds presently in clinical trials, as well as new compounds/extracts that may enter trials in the future. We summarise information regarding mechanisms of action and active concentrations.

27 October 2025 in JMIR Cancer
Verified
Journal Article
Open access
VHVirginia Harrison
Virginia Harrison
KJKatie Jones
Katie Jones
CHCaroline Anna Clara Hyde
Caroline Anna Clara Hyde
Background: Lung cancer (LC) is the leading cause of cancer-related deaths worldwide and has a substantial impact on patients’ quality of life (QoL) and psychological well-being, due to complex physical, emotional, and social challenges. Addressing these needs is critical; yet, many patients go unsupported. eHealth (using information and communication technology to deliver health-related services) offers a scalable way to provide timely, personalized care for people living with LC. Objective: This review aimed to evaluate the impact of eHealth interventions on QoL and psychological well-being in patients with LC, and characterize the different strategies used. Methods: A systematic review was conducted following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Literature searches across 6 databases (PubMed, PsycINFO, MEDLINE, Scopus, Web of Science, and CINAHL) were performed between December 2023 and February 2024. Eligible studies included experimental and quantitative designs involving adults (≥18 years) diagnosed with LC. Interventions were required at least 1 eHealth component, and studies had to report outcomes on QoL or psychological well-being. Data extraction focused on study characteristics, intervention details, outcomes, engagement and acceptability metrics. Study quality was assessed using a modified Downs and Black checklist, and a synthesis without meta-analysis was conducted due to study heterogeneity. Results: A total of 7065 records were screened, with 33 studies meeting inclusion criteria; of these, 30 were suitable for quantitative synthesis, comprising 2654 individual participants and 231 patient-caregiver dyads. eHealth strategies included: patient education (n=2), digital symptom monitoring (n=6), physical activity programs (n=8), psychological support (n=5), nurse-led interventions (n=5), and multicomponent portals or platforms (n=7). For QoL, the most consistent benefits were observed in multicomponent (5/5) and nurse-led (3/3) interventions, followed by physical activity (4/6) and symptom monitoring (4/6) approaches. For psychological well-being, multicomponent (4/4), nurse-led (2/2), and physical activity (6/6) interventions all demonstrated consistent positive effects. Psychological interventions showed mixed effects overall, although mindfulness-based programs (2/2) consistently reduced psychological symptoms. Key factors linked to positive outcomes included personalization, delivery via apps or web-based platforms, longer intervention duration, and clinician involvement. User acceptability was generally high, and engagement was variable, although both were rarely measured. Conclusions: eHealth interventions can have a positive effect on QoL and psychological well-being for people with LC. Multifaceted programs addressing diverse patient needs were found to be particularly effective. However, variation in study quality, small sample sizes, and inconsistent measurement of engagement and acceptability limit the strength of conclusions. Thus, while eHealth solutions have the potential to address significant gaps in LC care and improve patient outcomes, further research is needed. To realize their full potential, future research should prioritize developing and evaluating tailored, scalable eHealth solutions with robust designs, standardized outcomes, and strategies to enhance patient engagement and implementation in routine care. Trial Registration: PROSPERO CRD42024509607; https://tinyurl.com/ycst2r8k

23 December 2024 in JMIR Preprints
Verified
Preprint
Open access
VHVirginia Harrison
Virginia Harrison
KJKatie Jones
Katie Jones
CHCaroline Anna Clara Hyde
Caroline Anna Clara Hyde
BACKGROUND Lung cancer (LC) is the leading cause of cancer-related deaths worldwide and has a substantial impact on patients’ quality of life (QoL) and psychological well-being, due to complex physical, emotional, and social challenges. Addressing these needs is critical; yet, many patients go unsupported. eHealth (using information and communication technology to deliver health-related services) offers a scalable way to provide timely, personalized care for people living with LC. OBJECTIVE This review aimed to evaluate the impact of eHealth interventions on QoL and psychological well-being in patients with LC, and characterize the different strategies used. METHODS A systematic review was conducted following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Literature searches across 6 databases (PubMed, PsycINFO, MEDLINE, Scopus, Web of Science, and CINAHL) were performed between December 2023 and February 2024. Eligible studies included experimental and quantitative designs involving adults (≥18 years) diagnosed with LC. Interventions were required at least 1 eHealth component, and studies had to report outcomes on QoL or psychological well-being. Data extraction focused on study characteristics, intervention details, outcomes, engagement and acceptability metrics. Study quality was assessed using a modified Downs and Black checklist, and a synthesis without meta-analysis was conducted due to study heterogeneity. RESULTS A total of 7065 records were screened, with 33 studies meeting inclusion criteria; of these, 30 were suitable for quantitative synthesis, comprising 2654 individual participants and 231 patient-caregiver dyads. eHealth strategies included: patient education (n=2), digital symptom monitoring (n=6), physical activity programs (n=8), psychological support (n=5), nurse-led interventions (n=5), and multicomponent portals or platforms (n=7). For QoL, the most consistent benefits were observed in multicomponent (5/5) and nurse-led (3/3) interventions, followed by physical activity (4/6) and symptom monitoring (4/6) approaches. For psychological well-being, multicomponent (4/4), nurse-led (2/2), and physical activity (6/6) interventions all demonstrated consistent positive effects. Psychological interventions showed mixed effects overall, although mindfulness-based programs (2/2) consistently reduced psychological symptoms. Key factors linked to positive outcomes included personalization, delivery via apps or web-based platforms, longer intervention duration, and clinician involvement. User acceptability was generally high, and engagement was variable, although both were rarely measured. CONCLUSIONS eHealth interventions can have a positive effect on QoL and psychological well-being for people with LC. Multifaceted programs addressing diverse patient needs were found to be particularly effective. However, variation in study quality, small sample sizes, and inconsistent measurement of engagement and acceptability limit the strength of conclusions. Thus, while eHealth solutions have the potential to address significant gaps in LC care and improve patient outcomes, further research is needed. To realize their full potential, future research should prioritize developing and evaluating tailored, scalable eHealth solutions with robust designs, standardized outcomes, and strategies to enhance patient engagement and implementation in routine care. CLINICALTRIAL PROSPERO CRD42024509607; https://tinyurl.com/ycst2r8k

2 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CHCaroline Anna Clara Hyde
Caroline Anna Clara Hyde
Dementia affects approximately 55 million people worldwide, yet the psychological experience of diagnosis and the determinants of post-diagnostic wellbeing remain underexplored relative to biomedical research priorities. The existing literature has been predominantly deficit-oriented, focusing on cognitive decline, neuropsychiatric symptoms, and carer burden, with limited attention to preserved psychological capacities and what supports flourishing following diagnosis. This narrative review applies a positive psychology framework to synthesise evidence on meaning, purpose, hope, and post-diagnostic adjustment in early-stage dementia. A central empirical observation motivating the review is the wellbeing paradox: the consistent finding that subjective wellbeing in early-to-moderate dementia is frequently higher than carers and clinicians predict, and is more strongly associated with psychosocial variables than with objective cognitive status. Evidence from the IDEAL cohort and related longitudinal research demonstrates that emotional responsiveness, need satisfaction, and capacity for meaning-making are preserved in early-stage dementia and constitute clinically relevant assets. Four positive psychology constructs are identified as evidence-based targets for intervention: hope, self-compassion, social identity, and meaningful engagement. Clinical implications include the integration of strengths-based assessment, meaning-centred group interventions, structured peer support, and validated positive outcome measures into post-diagnostic care pathways. Health equity considerations and research priorities are addressed, including the underrepresentation of minority ethnic communities and people with young-onset dementia in existing research. The review argues that meaningful progress requires deliberate reorientation of clinical, commissioning, and research priorities toward a positive psychology framework for dementia care.

Verified
Journal Article
Open access
PDF file
CHCaroline Anna Clara Hyde
Caroline Anna Clara Hyde
Dementia affects approximately 55 million people worldwide, yet the psychological experience of diagnosis and the determinants of post-diagnostic well-being remain underexplored relative to biomedical research priorities. The existing literature has been predominantly deficit-oriented, focusing on cognitive decline, neuropsychiatric symptoms, and carer burden, with limited attention to preserved psychological capacities and what supports flourishing following diagnosis. This narrative review applies a positive psychology framework to synthesise evidence on meaning, purpose, hope, and post-diagnostic adjustment in early-stage dementia. A central empirical observation motivating the review: the well-being paradox—subjective well-being in early-to-moderate dementia is frequently higher than carers and clinicians predict. It is also more strongly associated with psychosocial variables than with objective cognitive status. Evidence from the IDEAL (Improving the experience of Dementia and Enhancing Active Life) cohort and related longitudinal research demonstrates that emotional responsiveness, need satisfaction, and capacity for meaning-making are preserved in early-stage dementia and constitute clinically relevant assets. Four positive psychology constructs are identified as evidence-based targets for intervention: hope, self-compassion, social identity, and meaningful engagement. Clinical implications include integrating strengths-based assessment, meaning-centred group interventions, structured peer support, and validated positive outcome measures into post-diagnostic care pathways. Health equity considerations and research priorities are addressed, including the underrepresentation of minority ethnic communities and people with young-onset dementia in existing research. The review argues that meaningful progress requires deliberate reorientation of clinical, commissioning, and research priorities toward a positive psychology framework for dementia care.